Hanmi Science to Attend MEDICA in Germany, Expand Overseas Sales Channels for Surgical Hemostatic Agents

[Financial News] Hanmi Science is turning to its surgical hemostatic agents to break into overseas medical device markets. After securing its first export contract and generating sales following its participation in a German medical device trade fair last year, the company will focus this year on strengthening ties with existing partners and finding new overseas distribution channels.
Hanmi Science announced on the 12th that it will participate in MEDICA 2026, the world's largest medical device trade fair, to be held in Düsseldorf, Germany, from the 16th through the 19th.
The items on display will be three surgical hemostatic agents developed by Teracion Biomedical, a company specializing in biosurgery, for which Hanmi Science has secured overseas sales rights: Woodsfix, an absorbable powdered adjunctive hemostat; TabloWax, a poloxamer-based absorbable bone hemostat; and ActiClot, an absorbable hemostat made using thrombin and plant-based starch.
Since participating in MEDICA last year, Hanmi Science has continued discussions with overseas buyers, leading to its first export contract and actual sales. This year, it plans to broaden its export base by expanding cooperation with existing partners while seeking new customers.
At the trade fair, Hanmi Science plans to discuss potential business partnerships with overseas medical device distributors and pursue expanded international sales of its hemostatic product line.

[email protected] Jung Sang-hee Reporter